SIM
TLSA icon

Studio Investment Management’s Tiziana Life Sciences TLSA Stock Holding History

Studio Investment Management’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-302
Closed -$211 – 347
2024
Q4 		$211 Buy
+302
New +$279 ﹤0.01% 313

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Studio Investment Management's TLSA Position: Q1 2025 in Review

Studio Investment Management sold out of Tiziana Life Sciences (TLSA) in Q1 2025, closing a stake of 302 shares — an estimated $211 sold.

Studio Investment Management first reported a position in TLSA in Q4 2024 and held it in 1 quarter. The position peaked at $211 in Q4 2024. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2025.

  • Studio Investment Management reported no remaining Tiziana Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Studio Investment Management sold 302 Tiziana Life Sciences shares in Q1 2025, an estimated $211.
  • Studio Investment Management first reported a position in Tiziana Life Sciences in Q4 2024 and held it in 1 quarter.
  • Studio Investment Management's Tiziana Life Sciences position peaked at $211 in Q4 2024.
  • 32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2025.

Based on Studio Investment Management's 13F filing for Q1 2025, filed 14 May 2025.